What is PUMA BIOTECHNOLOGY INC's Market Cap?

PUMA BIOTECHNOLOGY INC's Market Cap is $484.7M, based on as-reported figures from SEC (XBRL) filings.

What is PUMA BIOTECHNOLOGY INC's Enterprise Value?

PUMA BIOTECHNOLOGY INC's Enterprise Value is $390.8M, based on as-reported figures from SEC (XBRL) filings.

What is PUMA BIOTECHNOLOGY INC's Trailing P/E?

PUMA BIOTECHNOLOGY INC's Trailing P/E is 18.1×, based on as-reported figures from SEC (XBRL) filings.

What is PUMA BIOTECHNOLOGY INC's Price / Sales?

PUMA BIOTECHNOLOGY INC's Price / Sales is 2.1×, based on as-reported figures from SEC (XBRL) filings.

What is PUMA BIOTECHNOLOGY INC's EV / Revenue?

PUMA BIOTECHNOLOGY INC's EV / Revenue is 1.7×, based on as-reported figures from SEC (XBRL) filings.

What is PUMA BIOTECHNOLOGY INC's EV / EBITDA?

PUMA BIOTECHNOLOGY INC's EV / EBITDA is 9.8×, based on as-reported figures from SEC (XBRL) filings.

What is PUMA BIOTECHNOLOGY INC's Revenue (TTM)?

PUMA BIOTECHNOLOGY INC's Revenue (TTM) is $231.2M, based on as-reported figures from SEC (XBRL) filings.

What is PUMA BIOTECHNOLOGY INC's Net Income (TTM)?

PUMA BIOTECHNOLOGY INC's Net Income (TTM) is $26.7M, based on as-reported figures from SEC (XBRL) filings.

What is PUMA BIOTECHNOLOGY INC's EBITDA?

PUMA BIOTECHNOLOGY INC's EBITDA is $40.9M, based on as-reported figures from SEC (XBRL) filings.

What is PUMA BIOTECHNOLOGY INC's Diluted EPS (TTM)?

PUMA BIOTECHNOLOGY INC's Diluted EPS (TTM) is 0.52, based on as-reported figures from SEC (XBRL) filings.

PUMA BIOTECHNOLOGY INC (PBYI) Financial Statements

PUMA BIOTECHNOLOGY INC

SIC 2834 · PHARMACEUTICAL PREPARATIONS

FIGI BBG001TFZB81

XNAS · usd

9.39▼ 0.16 (-1.68%)

As of 2026-09-08

Valuation

Market Cap

Enterprise Value

Trailing P/E

Price / Sales

EV / Revenue

EV / EBITDA

Financial Highlights

Revenue (TTM)

Net Income (TTM)

EBITDA

Diluted EPS (TTM)

EBITDA Margin

Net Debt

Trading Information

Previous Close9.55

Day's Range8.85 – 9.57

52-Week Range4.30 – 9.74

Volume365.4K

Avg Volume308.0K

Share Statistics

Shares Outstanding

Employees179

ExchangeXNAS

Listed2012-03-21

Share count as of August 3, 2026

ViewDetail

Period

Loading Income Statement…

Key questions about PUMA BIOTECHNOLOGY INC (PBYI)

What is PUMA BIOTECHNOLOGY INC's Market Cap?: PUMA BIOTECHNOLOGY INC's Market Cap is $484.7M, based on as-reported figures from SEC (XBRL) filings.
What is PUMA BIOTECHNOLOGY INC's Enterprise Value?: PUMA BIOTECHNOLOGY INC's Enterprise Value is $390.8M, based on as-reported figures from SEC (XBRL) filings.
What is PUMA BIOTECHNOLOGY INC's Trailing P/E?: PUMA BIOTECHNOLOGY INC's Trailing P/E is 18.1×, based on as-reported figures from SEC (XBRL) filings.
What is PUMA BIOTECHNOLOGY INC's Price / Sales?: PUMA BIOTECHNOLOGY INC's Price / Sales is 2.1×, based on as-reported figures from SEC (XBRL) filings.
What is PUMA BIOTECHNOLOGY INC's EV / Revenue?: PUMA BIOTECHNOLOGY INC's EV / Revenue is 1.7×, based on as-reported figures from SEC (XBRL) filings.
What is PUMA BIOTECHNOLOGY INC's EV / EBITDA?: PUMA BIOTECHNOLOGY INC's EV / EBITDA is 9.8×, based on as-reported figures from SEC (XBRL) filings.
What is PUMA BIOTECHNOLOGY INC's Revenue (TTM)?: PUMA BIOTECHNOLOGY INC's Revenue (TTM) is $231.2M, based on as-reported figures from SEC (XBRL) filings.
What is PUMA BIOTECHNOLOGY INC's Net Income (TTM)?: PUMA BIOTECHNOLOGY INC's Net Income (TTM) is $26.7M, based on as-reported figures from SEC (XBRL) filings.
What is PUMA BIOTECHNOLOGY INC's EBITDA?: PUMA BIOTECHNOLOGY INC's EBITDA is $40.9M, based on as-reported figures from SEC (XBRL) filings.
What is PUMA BIOTECHNOLOGY INC's Diluted EPS (TTM)?: PUMA BIOTECHNOLOGY INC's Diluted EPS (TTM) is 0.52, based on as-reported figures from SEC (XBRL) filings.